| April 2020
|BIOSAFETY - Back
Health, Safety, and Environment
Visit the Health,
Safety, & Environment website.
HSE sponsors a variety of instructor-led and online training course
options and dates.
Have a New Research Interest including Biological
Materials? Don't Forget to Register Your Research!
The Biosafety Office assists the Johns Hopkins community in maintaining
a safe work environment that is compliant with federal, state and community
regulations. Our goal is to serve as a technical knowledgebase and training
resource for biological safety issues on campus.
Contact Biosafety in the department of Health,
Safety, and Environment (HSE) and get help from the experts about how
to set up your lab, maintain compliance with required procedures, and
so much more.
Biosafety at Johns
Hopkins is overseen and reviewed by the Institutional Biosafety Committee
(IBC). The goals of the IBC are:
- To ensure that reasonable and proper precautions
and procedures are used and facilities free of hazards are available
for research activities involving biological agents.
- Prevent potential threats to the safety of
JH personnel from biological hazards.
- Assist and advise Johns Hopkins Principal Investigators
and research personnel to become knowledgeable about and comply with
appropriate international, federal, state, and local biosafety regulations
or guidelines associated with research.
The IBC operates in close association with Biological
Safety Officer (BSO) and his or her staff with regard to compliance
with federal, state, and local biosafety regulations.
In order for the IBC and the division of Biological
Safety to serve as helpful resources in your research efforts, it is
imperative that you work closely with your Laboratory Director/ Principal
Investigator to ensure that all applicable biological materials are
registered with the IBC.
- Principal Investigators must register the
use or possession of Recombinant or Synthetic Nucleic Acid Molecules,
Infectious Agents/Pathogens, Biological Toxins, and Human Tissues
on the Homewood, East Baltimore, Bayview, Montgomery County, All Children's
Hospital, and JH Community Hospital campuses with the Biosafety Office
of the Johns Hopkins Institutions. Investigators are responsible for
registering the above-listed research material and describing the
protocols in which they will be used. This rule applies to all independent
investigators. Collaborators may not "piggy-back"
on each other's registrations. Postdoctoral fellows, graduate
students, and research associates are covered by the registrations
of their Principal Investigator. The Principal Investigator is
ultimately responsible for the registration, training, and safe handling
of research materials used by their personnel.
- Registration and IBC approval must occur prior
to the use or possession of these materials. Registration forms may
be found at http://www.hopkinsmedicine.org/hse/forms/forms.html.
- Registrations are approved for a one-year term.
Registrations may be renewed by completion and return of the registration
update form, which is sent to the investigator by the Biosafety Office
prior to the registration expiration date.
- Registrations are necessary for IACUC approval.
Investigators must hold current registrations for Recombinant or Synthetic
Nucleic Acid Molecules, Infectious Agents/Pathogens, Biological Toxins
and/or Human Tissue if their projects involve the use of these materials
For more information regarding the policy on
Institutional Biosafety Committee objectives and requirements from the
department of Health Safety and Environment please visit: https://hpo.johnshopkins.edu/hse/?event=section§ionid=1004
and select policy HSE500.
BioRAFT Chemical Registry
Principal Investigators, please remember to complete the initial lab
registration in BioRAFT. BioRAFT is an online, 24/7 accessible, software
package that is being deployed to serve as the chemical registry for
laboratory spaces located on the campuses of Johns Hopkins. Completion
of the lab registration in BioRAFT will be reviewed as part of the annual
departmental safety survey.
To access BioRAFT,
please go to: https://jhu.bioraft.com.
After logging in using your JHED, the General Setup Wizard will guide
you through the lab set-up. We greatly appreciate your assistance with
Johns Hopkins 2019-20 Flu Campaign
Flu vaccine for Johns Hopkins employees is here! The inactivated influenza
vaccine (injectable) will be administered to Hopkins employees beginning
October 7th, 2019. (Please see locations & schedules below)
The Johns Hopkins Institutions
require health care providers to have annual influenza vaccination or
possess an approved qualified
exception. If vaccinated
outside of Johns Hopkins, a proof of immunization must be provided
to Occupational Health Services to receive credit for the vaccination.
Please review the
Mandatory Seasonal Influenza Vaccination Policy (HSE048) for more
The Influenza vaccine
will be administered to Physicians, Faculty, Staff, Employees, Students
and Volunteers by Occupational Health Services as listed below.
Have questions about
the mandatory flu vaccination policy? Read
Dual Use Research
of Concern (DURC) policies:
The United States Government's Policy for Institutional Oversight of
Life Sciences Dual Use Research of Concern (DURC) went into effect on
September 24, 2015. DURC is defined by the federal government as:
that, based on current understanding, can be reasonably anticipated
to provide knowledge, information, products, or technologies that
could be directly misapplied to pose a significant threat with broad
potential consequences to public health and safety, agricultural crops
and other plants, animals, the environment, materiel,
or national security."
In the federal policy's
current form, there are 15 agents (microbial entities and toxins) that
fall under institutional DURC oversight. The current list of 15 agents
as well as a list of 7 categories of experiments or experimental effects
that would constitute DURC may be found at this website: http://www.hopkinsmedicine.org/hse/ire/regulations.html.
Questions regarding DURC should be directed to the Biosafety
Office at email@example.com or
Return to top of Biosafety